Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Molecular Assessment for Gastro-Esophageal Cancer [NA]
A molecular assessment trial for gastro-esophageal cancers is currently recruiting at KU Leuven. The study encompasses Esophageal cancer, Ga…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2 [Phase 4]
A Phase 4 clinical trial is evaluating Helicobacter pylori screening and treatment in an at-risk South Florida community. The study is curre…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients [NA]
This clinical trial update describes a study evaluating the effectiveness of managing chemotherapy side effects using electronic patient-rep…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 [Phase 2]
Phase 2 clinical trial evaluating AZD0901 in advanced solid tumours expressing Claudin18.2 is currently recruiting, including gastric cancer…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer [Phase 2]
This document provides an update on an ongoing Phase 1b/2 clinical trial evaluating SHR-A1811 combinations in advanced HER2-expressing gastr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)
This clinical trial update announces ongoing recruitment for a study of trastuzumab deruxtecan in adults with HER2-positive advanced gastric…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating a quadruple combination therapy (fruquintinib, nab-paclitaxel, iparomlimab, and tuvonralimab) for second…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer
This clinical trial investigates how patient age influences treatment choices and prognosis in resectable gastric cancer, incorporating next…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 3]
A Phase III trial evaluating SHR-A1811 with chemotherapy and Adebrelimab in untreated, unresectable or metastatic gastric or gastroesophagea…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma [Phase 3]
A Phase III clinical trial is evaluating Cadonilimab in combination with the SOX chemotherapy regimen as perioperative treatment for patient…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota
A clinical trial from Fudan University is evaluating whether adding a PD-1 monoclonal antibody to chemotherapy improves outcomes in metastat…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: First-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Dual Immunotherapy Combined With Chemotherapy [Phase 2]
A Phase 2 trial evaluating first-line dual immunotherapy plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma; the stud…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
This clinical trial update describes a study using multimodal artificial intelligence to predict response to neoadjuvant immunotherapy in ga…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CONFIRM: Magnetic Resonance Guided Radiation Therapy [NA]
ClinicalTrials.gov study CONFIRM is evaluating magnetic resonance guided radiation therapy and is currently recruiting for several cancers, …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer [Phase 2]
Phase 2 trial evaluating neratinib in combination with chemotherapy, trastuzumab, and pembrolizumab for HER2-positive gastroesophageal cance…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer [EARLY_Phase 1]
An early-phase study evaluating CBG131 CAR-T cell therapy targeting CLDN18.2 for advanced gastric and pancreatic cancer. The trial is not ye…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX [Phase 2]
Phase 2 trial update for Megestrol Acetate oral suspension to manage cancer cachexia in patients with stage III gastric cancer or gastroesop…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Validation of AI-ENDO System in Endoscopic Submucosal Dissection [NA]
A clinical trial is validating the AI-ENDO System for use during endoscopic submucosal dissection of superficial lesions in the esophagus, s…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating a binary oncolytic adenovirus in combination with a HER2-specific autologous CAR-VST for advanced HER2-pos…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors [Phase 1]
This clinical trial update notes the completion of a Phase 1 study of SHR-A1811 in patients with HER2-expressing tumors, including gastric c…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma. [Phase 3]
LM-302 is being evaluated in a Phase 3 trial for Claudin18.2-positive gastric and gastroesophageal junction adenocarcinoma; the study is cur…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of SH009 Injection in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 clinical trial update for SH009 Injection in patients with advanced solid tumors, currently recruiting across multiple indications…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma
This clinical trial update reports ongoing recruitment for second-line regimens based on albumin-bound paclitaxel to treat locally advanced …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: CTNNA1 Familial Expansion Study
The CTNNA1 Familial Expansion Study is currently recruiting to investigate CTNNA1 gene mutations in gastric cancer and related cancers, incl…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma. [Phase 3]
Phase 3 clinical study evaluating LM-302 in combination with tislelizumab, and tislelizumab-based chemotherapy, for gastric or gastroesophag…